Fat-Rich Coronary Plaques May Identify Who Benefits From Preventive Stenting
A PREVENT trial analysis links preventive stenting to fewer cardiac events in patients with fat-rich plaques, but not in those without them.
Summary
The fat inside coronary artery plaques may help identify who benefits from preventive stenting, even when those plaques do not significantly block blood flow. Researchers analyzed 598 patients from the PREVENT trial, following them for a median of 5.6 years. Among patients with fat-rich plaques, a combined outcome of serious cardiac events, additional procedures, or hospitalization for worsening chest pain occurred in 7.3% receiving preventive stenting versus 17.6% receiving medical therapy alone. Patients without fat-rich plaques showed no significant benefit from stenting. The findings suggest that plaque composition could help doctors select treatment more precisely. However, this was a post hoc subgroup analysis, not definitive evidence for routine preventive stenting. The summary is based only on the abstract, which does not detail procedural harms or establish a mortality benefit.
Detailed Summary
Heart attacks can develop when fatty deposits inside coronary arteries rupture even if they do not substantially restrict blood flow. Identifying which deposits warrant preventive treatment could help preserve cardiovascular health. This analysis examined whether measuring fat within artery plaques can identify patients more likely to benefit from preventive stenting rather than medical therapy alone.
Researchers analyzed a subset of the randomized PREVENT trial involving 598 patients with 632 coronary lesions. Participants averaged 64 years old, and 27.9% were women. All selected lesions had substantial plaque buildup and small internal openings but did not significantly impede blood flow. Specialized imaging classified 223 patients as having plaques with high lipid content.
Over a median 5.6 years, the combined outcome occurred in 12.5% of patients with fatty plaques versus 4.7% without them. This outcome included cardiac death, heart attack in the affected vessel, additional procedures prompted by inadequate blood supply, or hospitalization for unstable or worsening chest pain. Among patients with fatty plaques, event rates were 7.3% with preventive stenting versus 17.6% with medical therapy alone.
After statistical adjustment, preventive stenting was associated with a 77% lower hazard of the combined outcome in this group. No significant benefit appeared among patients without fatty plaques, whose event rates were 5.5% versus 4.2%. These findings suggest plaque composition may help guide treatment selection beyond plaque size alone. They do not establish that stenting reduces mortality or replaces cardiovascular risk management.
Important caveats limit immediate clinical adoption. This was a post hoc analysis of a selected subgroup, not a dedicated trial prospectively testing this imaging strategy. Treatment was not blinded, and the combined outcome included hospitalizations and repeat procedures. The abstract does not provide detailed procedural harms or individual outcome results. This summary relies on the abstract only; confirmation is needed before changing routine practice.
Key Findings
- Fat-rich plaques were identified in 37.3% of analyzed patients using specialized imaging inside coronary arteries.
- Among patients with fat-rich plaques, combined cardiac outcome rates were 7.3% with preventive PCI versus 17.6% with medical therapy alone.
- Preventive PCI showed no significant benefit without fat-rich plaques; outcome rates were 5.5% versus 4.2%.
- Plaque composition may help refine treatment selection, but these exploratory findings do not justify routine preventive stenting.
- The combined outcome included hospitalizations and repeat procedures; the abstract does not establish a mortality benefit.
Methodology
This post hoc analysis included 598 of 1,606 participants in the multicenter, open-label, randomized PREVENT trial, with median follow-up of 5.6 years. Selected lesions had fractional flow reserve above 0.80, plaque burden above 70%, and minimal lumen area below 4 mm²; near-infrared spectroscopy defined lipid-rich plaques using a maximum lipid core burden index above 315 over a 4-mm segment. Researchers compared a composite cardiac outcome by treatment and plaque lipid status, finding a significant treatment-by-lipid-status interaction.
Study Limitations
This summary is based on the abstract only, without access to the full paper. The post hoc analysis involved a selected imaging subgroup, and the open-label design may influence hospitalization or revascularization components of the composite outcome. The abstract does not provide detailed procedural harms or component-specific results, and women represented only 27.9% of participants.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: